RIPK3 and autoimmune thrombocytopenic purpura: In conclusion, our work demonstrated the upregulation of necroptosis markers (MLKL and RIPK3) in ITP patients as well as their significant correlations with platelet count, bleeding severity and cortisol treatment response in those patients, implying that necroptosis may play a pivotal role in ITP pathogenesis.